Bexagliflozin

Chemical formula: C₂₄H₂₉ClO₇  Molecular mass: 464.16 g/mol  PubChem compound: 25195624

Therapeutic indications

Bexagliflozin is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 years old or older)

Bexagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Limitations of use: Bexagliflozin is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Bexagliflozin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Volume depletion

Extracellular fluid volume depletion

1,5-anhydroglucitol assay

at least one of
1,5-ANHYDRO-D-GLUCITOL
Glucose measurement

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2023: BRENZAVVY Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈